BGA
ARMP icon

Belmont Global Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Belmont Global Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-893
Closed -$492K – 65
2016
Q1 		$492K Buy
893
+334
+60% +$171K 0.5% 38
2015
Q4 		$312K Buy
559
+188
+51% +$144K 0.4% 56
2015
Q3 		$205K Buy
+371
New +$339K 0.35% 52

Other funds holding ARMP

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return

Belmont Global Advisors's ARMP Position: Q2 2016 in Review

Belmont Global Advisors sold out of Armata Pharmaceuticals (ARMP) in Q2 2016, closing a stake of 893 shares — an estimated $492K sold.

Belmont Global Advisors first reported a position in ARMP in Q3 2015 and held it in 3 quarters. The position peaked at $492K in Q1 2016. 17 funds tracked by Wall St. Rank hold ARMP as of Q2 2016.

  • Belmont Global Advisors reported no remaining Armata Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Belmont Global Advisors sold 893 Armata Pharmaceuticals shares in Q2 2016, an estimated $492K.
  • Belmont Global Advisors first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Belmont Global Advisors's Armata Pharmaceuticals position peaked at $492K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2016.

Based on Belmont Global Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.